This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Recovering from budget neglect requires a clear plan: rebuild essential budgets, tackle debt strategically, and track progress weekly.
28,655 articlesA top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Two popular consumer sector ETFs sit at the crossroads of liquidity and diversification. XLY concentrates on large‑ca...
Federal Reserve Governor Michael S. Barr outlined three AI-driven labor-market futures, including a worst-case jobles...
SpaceX reportedly trims its IPO ambitions, signaling a lower target valuation looming. This article breaks down what ...
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...
A big new stake in Ryan Specialty Holdings hints at growing confidence from a niche investor. This article breaks dow...
In Japan, thousands of older workers sit near windows in near-idle roles as Western bosses push for AI and tighter pr...
A luxury of near-new mileage becomes a liability if a dealer claims a major repair. This article breaks down what hap...
Markets retreat as geopolitical risk and currency headwinds weigh on miners and industrials. Linde and Southern Coppe...
Dallas-Fort Worth is seeing a growth shift to the south, as new toll corridors and job centers spur homebuilding and ...
As markets shift in 2026, dividend-focused funds regain attention. This guide breaks down the ishares core high divid...
As global markets digest a dual threat from US AI policy and China's energy choke points, the G7 confronts a politica...